| Product Code: ETC8274888 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Cell And Gene Therapy Manufacturing Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Cell And Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 Mexico Cell And Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Scale, 2021 & 2031F |
3.7 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Mode, 2021 & 2031F |
3.8 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
4 Mexico Cell And Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development in the field of cell and gene therapy in Mexico |
4.2.2 Growing prevalence of chronic diseases driving the demand for innovative therapies |
4.2.3 Supportive regulatory environment promoting the development and manufacturing of cell and gene therapies in Mexico |
4.3 Market Restraints |
4.3.1 High manufacturing costs associated with cell and gene therapy production |
4.3.2 Limited availability of skilled workforce and specialized manufacturing facilities in Mexico |
5 Mexico Cell And Gene Therapy Manufacturing Market Trends |
6 Mexico Cell And Gene Therapy Manufacturing Market, By Types |
6.1 Mexico Cell And Gene Therapy Manufacturing Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell therapy manufacturing, 2021- 2031F |
6.1.4 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Gene therapy manufacturing, 2021- 2031F |
6.2 Mexico Cell And Gene Therapy Manufacturing Market, By Scale |
6.2.1 Overview and Analysis |
6.2.2 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Pre-commercial/R&D scale manufacturing, 2021- 2031F |
6.2.3 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Commercial scale manufacturing, 2021- 2031F |
6.3 Mexico Cell And Gene Therapy Manufacturing Market, By Mode |
6.3.1 Overview and Analysis |
6.3.2 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Contract manufacturing, 2021- 2031F |
6.3.3 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume, By In-house manufacturing, 2021- 2031F |
6.4 Mexico Cell And Gene Therapy Manufacturing Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell processing, 2021- 2031F |
6.4.3 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell banking, 2021- 2031F |
6.4.4 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Process development, 2021- 2031F |
6.4.5 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Fill & finish operations, 2021- 2031F |
6.4.6 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Analytical and quality testing, 2021- 2031F |
6.4.7 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Raw material testing, 2021- 2031F |
6.4.8 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
6.4.9 Mexico Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
7 Mexico Cell And Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 Mexico Cell And Gene Therapy Manufacturing Market Export to Major Countries |
7.2 Mexico Cell And Gene Therapy Manufacturing Market Imports from Major Countries |
8 Mexico Cell And Gene Therapy Manufacturing Market Key Performance Indicators |
8.1 Percentage of clinical trials utilizing cell and gene therapies conducted in Mexico |
8.2 Number of partnerships between Mexican research institutions and international biotech companies in the field of cell and gene therapy |
8.3 Government funding allocated to support the growth of cell and gene therapy manufacturing in Mexico |
9 Mexico Cell And Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 Mexico Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 Mexico Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Scale, 2021 & 2031F |
9.3 Mexico Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Mode, 2021 & 2031F |
9.4 Mexico Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
10 Mexico Cell And Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 Mexico Cell And Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Mexico Cell And Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here